Tag: malignant breast neoplasm

Cancer Screening Stopped by Pandemic: Repercussions to Come?

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Last year, cancer screening programs around the world ground to a...

Patients With Cancer Need Both Doses of COVID Vax

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The first report on responses to COVID-19 vaccination among patients with...

No Benefit Seen With Everolimus in Early Breast Cancer

Adding everolimus to adjuvant hormone therapy for early ER+, HER2- breast cancer does not offer any benefit over hormone therapy alone, according to results of...

How Patients Decide on Surgery

Patients consider the risk of cancer and menopause, as well as other factors, when making decisions about ovarian cancer prevention surgery, according to a small...

Liquid vs Tissue Biopsy in Prostate Cancer: Why Not Both?

The genomic landscape of circulating tumor DNA (ctDNA) was comparable to the landscape of tissue biopsies in a large study of patients with metastatic castration-resistant...

New Approach to Breast Screening Based on Breast Density at 40

A new approach to breast screening proposes that all women should have a baseline  evaluation of breast density by mammography at the age of 40....

Obesity ‘Clearly’ Not Tied to Worse Survival in MBC

The relationship between obesity and overweight and breast cancer has some elements of mystery. But this is not one of them: in metastatic breast cancer...

Study Flags Cardiovascular Disease in Men With Breast Cancer

Cardiovascular disease and related risk factors can be common among male breast cancer patients, suggests a small study in this rare malignancy. Among 24 male...

First Mammography Guidelines for Older Breast Cancer Survivors

The first guidelines ever released for screening mammography for older survivors of breast cancer (>75 years) recommend that routine mammography be discontinued for women whose...

Global Demand for Cancer Surgery Expected to Soar

Global demand for cancer surgery will increase by 52% by 2040, with underresourced, low-income countries shouldering the greatest burden, a modeling study suggests. A second...

Adding Liothyronine for Hypothyroidism Doesn’t Up Breast Cancer Risk

The combination of liothyronine (LT3) with levothyroxine (LT4) for the treatment of hypothyroidism shows no evidence of any increased risk of breast cancer in a...

Tool Predicts Severe Toxicity From Chemo in Breast Cancer

A new tool for predicting the risk of severe chemotherapy toxicity in older adults with early-stage breast cancer outperforms existing models and should help older...

Entinostat Doesn’t Overcome Endocrine Resistance in Breast Cancer

The histone deacetylase (HDAC) inhibitor entinostat failed to overcome resistance to endocrine therapy in hormone receptor–positive, HER2-negative, advanced breast cancer in a phase 3 trial....

After 48 Years, NCI Aims to Track Breast Cancer Recurrences

  Patients with breast cancer want accurate information on the risk of their cancer recurring once they have completed treatment. “I would like to know...

New Data Strengthen Case for Prechemotherapy Statins

Evidence supporting the use of statins to protect against cardiotoxic chemotherapy has been strengthened with new data from a propensity-matched analysis. Among women with breast...

Even for Wealthy, US Healthcare Can’t Match Care in Other Nations

(Reuters Health) – When it comes to health care, even privileged white Americans fare worse than the average citizens of 12 other developed countries, a...

Doctors Underreport Side Effects of Breast Irradiation

There is a substantial mismatch between patient and physician reports of toxicity during radiotherapy for breast cancer, according to an analysis of nearly 10,000 U.S....

Long-term APBI Cosmetic, Toxicity Data Reported

Long-term cosmetic and toxicity outcomes are good for both accelerated partial breast irradiation (APBI) delivered with 3D-conformal radiotherapy and whole-breast irradiation (WBI), with the latter...

Democrats Are Running Hard on Health Care in Georgia’s Runoffs

In this Nov. 20, 2020, photo, Vice President Mike Pence and Kelly Loeffler wave to the crowd during a Defend the Majority Rally in Canton,...

Most Common Cancer Diagnosis Globally: Breast Surpasses Lung

Breast cancer now tops the list of the most commonly diagnosed cancers worldwide, surpassing lung cancer for the first time, according to the latest global...

Pregnancy After Breast Cancer Doesn’t Increase Recurrence Risk

Breast cancer survivors are less likely to get pregnant and have higher risks of some delivery and fetal complications, according to a meta-analysis reported at the 2020...

Adding Atezolizumab to Chemo Doesn’t Worsen QOL in Early TNBC

Adding the immune checkpoint inhibitor atezolizumab to first-line therapy for early triple-negative breast cancer (TNBC) did not significantly worsen patients’ quality of life, according to...

First-in-Class ADC Has Benefit Across mTNBC Subgroups

The antibody–drug conjugate sacituzumab govitecan (SG) (Trodelvy) appears to be effective across biomarker subgroups for women with metastatic triple-negative breast cancer (mTNBC) that has progressed...

Even More Women May Forgo Chemo for Breast Cancer

More women with early-stage breast cancer may safely forgo chemotherapy, suggests an interim analysis that had a median follow-up of 5 years of the large-scale...

Charting of the Human Genome, 20 Years Later

Twenty years ago, President Bill Clinton announced completion of what was arguably one of the greatest advances of the modern era: the first draft sequence...